Viridian Therapeutics Inc (NAS:VRDN)
$ 12.34 0.74 (6.38%) Market Cap: 787.57 Mil Enterprise Value: 347.92 Mil PE Ratio: 0 PB Ratio: 2.06 GF Score: 46/100

miRagen Therapeutics Inc Annual Shareholders Meeting Transcript

May 21, 2020 / 03:00PM GMT
Release Date Price: $9.39 (-1.01%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Miragen Therapeutics, Inc. Annual Meeting.

I would now like to hand the conference over to your speaker today, Mr. Bill Marshall. Sir, please go ahead.

William Stuart Marshall
Miragen Therapeutics - Co-Founder, President, CEO & Director

Good morning. I'm Bill Marshall, the President, Chief Executive Officer and a Director of Miragen Therapeutics, Inc. Very happy to welcome you to the Miragen Therapeutics, Inc. 2020 Annual Stockholders Meeting. Since the meeting is being held virtually via live webcast originating from Boulder, Colorado, we will have stockholders attending via web portal.

Before I call the meeting to order, I'd like to introduce to you the members of the Board and the business team who are with us today. The other members of the Board are: Christopher J. Bowden, MD; Jeffrey S. Hatfield, the Chairperson of our Board; Thomas E. Hughes, PhD, the Chairperson of our Compensation Committee; Kevin Koch, PhD, the Chairperson of our Nominating and Corporate

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot